China Borun Pharmaceutical Under Investigation: Reporting Irregularities Shake Investor Confidence

China Borun Pharmaceutical faces scrutiny amid reporting irregularities, leading to a stock suspension and raising concerns about transparency in the Chinese pharmaceutical sector.